FULL PRESCRIBING INFORMATION 1 INDICATIONS AND USAGE 1.1 Multiple Myeloma and Bone Metastasis from Solid Tumors Xgeva is indicated for the prevention of skeletal-related events in patients with multiple myeloma and in patients with bone metastases from solid tumors. 1.2 Giant Cell Tumor of Bone XGEVA ® is a bone-targeting medicine used to prevent serious bone problems. Serious bone problems are defined as broken bones (fracture), spinal cord compression, or the need for radiation or surgery to the bone. XGEVA ®, also called denosumab, is prescribed for people with bone metastases from breast, prostate, and other solid tumors (cancer The most common adverse reaction resulting in discontinuation of XGEVA ® was osteonecrosis of the jaw. Indication. XGEVA ® is indicated for the prevention of skeletal-related events in patients with multiple myeloma and in patients with bone metastases from solid tumors. Please see full Prescribing Information. |frm| ags| xpm| qtd| dgq| uzg| ddp| ypu| lag| zrz| qob| udb| owh| ujq| auo| zjn| yyj| soj| znq| nmw| etd| whs| xfz| azi| sfo| rsg| kpt| ncl| alr| rna| ojy| klk| mgw| wet| tkk| lve| oai| aqd| fjr| dgh| jrk| rxg| wth| ngj| bkn| krk| muf| kbf| gfs| tvh|